John W. Cumming

Chief Executive Officer, Hologic.

Companies

T2 Biosystems, Inc.Board member Aug 6, 2014 to Jan 2, 2025¹
HologicPresident Jul 26, 2013 to Nov 20, 2013²
HologicChief executive officer May 5, 2006 to Nov 20, 2013³
HologicChair May 5, 2006 to Mar 9, 2011³
HologicBoard member Oct 24, 2007 to Nov 13, 2009⁴

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

T2 Biosystems, Inc.5,256 shares⁵Sep 15, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 15, 2023Exercised options 2,600 shares of T2 Biosystems, Inc.⁵
Jun 25, 2022Exercised options 81,967 shares of T2 Biosystems, Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGART2 Biosystems, Inc., Board member
2
SEC EDGARHologic, President
3
SEC EDGARHologic, Chief executive officer
4
SEC EDGARHologic, Board member
5
SEC EDGART2 Biosystems, Inc. shares after the filing of Sep 15, 2023
6
SEC EDGARForm 4 filed Jun 28, 2022